Loading…
CollPlant Biotechnologies Ltd. is projected to decline to $0.3051 by 2027, a -4% move from its current price of $0.318. CLGN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3038 | $0.318 | $0.3329 | 0.00% |
| Aug 6 | $0.298 | $0.318 | $0.3393 | +0.01% |
| Aug 7 | $0.2937 | $0.318 | $0.3443 | +0.01% |
| Aug 8 | $0.2902 | $0.318 | $0.3486 | +0.01% |
| Aug 9 | $0.287 | $0.318 | $0.3524 | +0.01% |
| Aug 10 | $0.2843 | $0.318 | $0.3559 | +0.02% |
| Aug 11 | $0.2817 | $0.3181 | $0.3591 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2817 | $0.3181 | $0.3591 | +0.02% |
| Week 2 | $0.268 | $0.3181 | $0.3777 | +0.04% |
| Week 3 | $0.2579 | $0.3182 | $0.3926 | +0.05% |
| Week 4 | $0.2497 | $0.3182 | $0.4056 | +0.07% |
| Week 5 | $0.2427 | $0.3183 | $0.4175 | +0.09% |
| Week 6 | $0.2365 | $0.3183 | $0.4285 | +0.11% |
| Week 7 | $0.231 | $0.3184 | $0.4389 | +0.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CollPlant Biotechnologies Ltd. is a healthcare company focused on regenerative and aesthetic medicine. It concentrates on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
The company’s products are based on recombinant human collagen (rhCollagen) produced using its proprietary technology.
CollPlant Biotechnologies Ltd. trades under the CLGN symbol and is categorized in Healthcare. The current price is $0.2728. The company has a market capitalization of $5.16M and ranks 5271 by market cap.
A major floor 46.6% below — a decisive break under it would weaken the trend.
The nearest floor, 14.2% below — buyers have tended to step in here.
The nearest ceiling, 34.6% above — a clean break opens room to run.
A major ceiling 135.8% above — clearing it would confirm fresh momentum.
Key CLGN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLGN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3064 | Buy | $0.2994 | Buy |
| MA 10 | $0.3111 | Buy | $0.3115 | Buy |
| MA 20 | $0.3368 | Sell | $0.326 | Sell |
| MA 50 | $0.3569 | Sell | $0.3656 | Sell |
| MA 100 | $0.4123 | Sell | $0.5231 | Sell |
| MA 200 | $1.01 | Sell | $0.9647 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.54 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -164.35 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -21.78 | Sell |
| Bollinger %B (20,2) | 0.01 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.51 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 24.30 | Buy |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.30 | Buy |
| ADX (14) | 17.28 | Neutral |
| ATR (14) | 0.01 | Info |
The near-term technical picture is Bearish as reflected by a 14-day RSI of 30. The stock trades with a 30-day range from $0.2016 to $0.3691, and its current price of $0.2728 sits near the established support at $0.273 and below the resistance at $0.428. TheMoving averages show the SMA50 at $0.3569 and the SMA200 at $1.01, placing the price under both averages.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.273 | $0.318 | $0.4442 | 0% | Neutral | |
| $0.2284 | $0.3051 | $0.4386 | -4% | Neutral | |
| $0.201 | $0.2826 | $0.4304 | -11% | Neutral | |
| $0.1949 | $0.2861 | $0.4554 | -10% | Neutral | |
| $0.228 | $0.348 | $0.5744 | +9% | Neutral | |
| $0.2442 | $0.3863 | $0.658 | +21% | Bullish | |
| $0.2539 | $0.4154 | $0.7276 | +31% | Bullish | |
| $0.2522 | $0.4263 | $0.7657 | +34% | Bullish | |
| $0.2183 | $0.3806 | $0.6994 | +20% | Neutral | |
| $0.2142 | $0.3849 | $0.7223 | +21% | Bullish | |
| $0.2566 | $0.5325 | $1.09 | +67% | Bullish | |
| $0.352 | $0.7821 | $1.80 | +146% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.273 | $0.318 | $0.4053 | +0.00% |
| September 2026 | $0.275 | $0.3316 | $0.4154 | +4.27% |
| October 2026 | $0.2613 | $0.3188 | $0.4065 | -3.86% |
| November 2026 | $0.2651 | $0.3266 | $0.4223 | +2.45% |
| December 2026 | $0.2729 | $0.3392 | $0.4442 | +3.86% |
Click any year to see its month-by-month CLGN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CLGN is projected to trade between $0.273 and $0.4442, averaging $0.318 — a potential gain of 0% from today's $0.318. A consolidation phase looks the most probable path here.
CollPlant Biotechnologies Ltd.'s 2027 outlook centres on $0.3051, within a $0.2284 to $0.4386 range. That is -4% versus the projected 2026 average. That marks a -4% change versus current levels. Price action looks broadly range-bound.
By 2028, CLGN could reach as high as $0.4304, with a base case around $0.2826 and support toward $0.201 — roughly -11% from $0.318. A consolidation phase looks the most probable path here.
Expect CLGN to range from $0.1949 to $0.4554 through 2029. The $0.2861 average target implies a -10% move from current prices. That is up +1% on the projected 2028 average. Price action looks broadly range-bound.
The CLGN price prediction for 2030 points to an average of $0.348 (low $0.228, high $0.5744) — a potential gain of +9% on today's $0.318. A consolidation phase looks the most probable path here.
In 2031, CLGN is projected to trade between $0.2442 and $0.658, averaging $0.3863 — a potential gain of +21% from today's $0.318. That is up +11% on the projected 2030 average. Momentum favours further upside here.
CollPlant Biotechnologies Ltd.'s 2032 outlook centres on $0.4154, within a $0.2539 to $0.7276 range. That is up +8% on the projected 2031 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CLGN could reach as high as $0.7657, with a base case around $0.4263 and support toward $0.2522 — roughly +34% from $0.318. Momentum favours further upside here.
Expect CLGN to range from $0.2183 to $0.6994 through 2034. The $0.3806 average target implies a +20% move from current prices. That is -11% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The CLGN price prediction for 2035 points to an average of $0.3849 (low $0.2142, high $0.7223) — a potential gain of +21% on today's $0.318. Momentum favours further upside here.
In 2040, CLGN is projected to trade between $0.2566 and $1.09, averaging $0.5325 — a potential gain of +67% from today's $0.318. That is up +38% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CollPlant Biotechnologies Ltd.'s 2050 outlook centres on $0.7821, within a $0.352 to $1.80 range. That is up +47% on the projected 2040 average. That marks a +146% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CLGN today (≈ 3,144.654088 CLGN) could be worth
$2,459.49
+$1,459.49 (+146%) by 2050 · US Dollar
Based on the average projected CLGN price of $0.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLGNwould be worth at today's price.
$1,000 invested in CLGN on Jul 31, 2025 (≈ 413.223127 CLGN) would be worth
$131.4
-$868.6 (-86.9%) today · 0.13× · US Dollar
Based on a CLGN entry price of $2.42 vs. today's $0.318.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.315 | $1,009.52 | +1.0% |
| 1 month ago | $0.34 | $935.29 | -6.5% |
| 3 months ago | $0.411 | $773.72 | -22.6% |
| 6 months ago | $1.84 | $172.83 | -82.7% |
| 1 year ago | $2.42 | $131.4 | -86.9% |
| All time (5.0y) ago | $17.6 | $18.07 | -98.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLGN forecast.
Our base-case forecast reaches $0.64 around 2050.
Implied market cap at $0.64: $12.1M
The multi-year forecast shows a neutral stance for 2026 with an average of $0.2728, a min of $0.2728, and a max of $0.3812, ROI 0, sentiment NEUTRAL. Beyond 2026, the path turns more bullish: 2027 is -4.3% ROI with an average of $0.261; 2028 at -10.9% ROI with an average of $0.243; 2029 at -10% ROI with an average of $0.2456. In 2030 the average rises to $0.2981 (ROI 9.3) with a max of $0.4922, followed by 2031 at $0.3322 (ROI 21.8) and 2032 at $0.3566 (ROI 30.7); 2033 at $0.3657 (ROI 34) and 2034 at $0.3271 (ROI 19.9), 2035 at $0.3299 (ROI 20.9) with bullish sentiment.
The forecast strengthens further in later years: 2040 at $0.4579 (ROI 67.9) and 2050 at $0.671 (ROI 146) with a max of $1.54. These figures imply meaningful upside potential in the longer horizon, balanced by lower near-term momentum; they are estimates, not guarantees.
Tap a question to reveal the answer.
2030 forecast min $0.1954, avg $0.2981, max $0.4922; ROI 9.3%; sentiment NEUTRAL.
Near-term forecast is NEUTRAL with 2026 avg $0.2728 and ROI 0%, and 2027-2029 showing negative ROI. Longer-term years 2031-2033 and beyond show bullish potential, but these are estimates and not guarantees.
The forecast maximum for 2050 is $1.54, which is above $1.50, with ROI 146%.
Current price $0.2728; Market cap $5.16M.
2031 forecast min $0.21, avg $0.3322, max $0.5659; ROI 21.8; sentiment BULLISH.
CollPlant Biotechnologies Ltd. Community Discussion
0Share your CollPlant Biotechnologies Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.